|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.06 INR | -2.91% |
|
-8.21% | -20.06% |
| Market Cap | 1.09B 11.35M 9.97M 9.27M 8.51M 15.99M 16.23M 110M 43.02M 537M 42.61M 41.7M 1.86B | P/E 2024 |
-12.2x | P/E 2025 | -28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 12.13M 10.66M 9.91M 9.09M 17.09M 17.35M 118M 45.98M 575M 45.55M 44.57M 1.99B | EV / Sales 2024 |
3.16x | EV / Sales 2025 | 3.93x |
| Free-Float |
44.12% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.91% | ||
| 1 week | -8.21% | ||
| Current month | -6.97% | ||
| 1 month | -12.86% | ||
| 3 months | -0.47% | ||
| 6 months | -2.23% | ||
| Current year | -20.06% |
| 1 week | 62.69 |  | 70.99 |
| 1 month | 62.69 | | 79.69 |
| Current year | 36.3 | | 82.44 |
| 1 year | 36.3 | | 164.02 |
| 3 years | 36.3 | | 198.86 |
| 5 years | 36.3 | | 198.86 |
| 10 years | 13.85 | | 198.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Mahajan
CEO | Chief Executive Officer | 58 | 23/01/2002 |
Prashant Rathi
CEO | Chief Executive Officer | - | 01/06/2026 |
Atul Ranchal
PSD | President | 57 | 23/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 23/11/2022 | |
| Director/Board Member | 62 | 10/09/2010 | |
| Director/Board Member | - | 23/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.91% | -8.21% | -59.52% | -22.91% | 20.07M | |
| -0.66% | -0.46% | +15.37% | +76.92% | 48.41B | |
| +2.20% | +1.18% | +62.94% | +112.48% | 34.99B | |
| +1.26% | -1.32% | -4.27% | +34.48% | 11.62B | |
| -0.46% | -3.92% | +15.26% | +80.81% | 11.47B | |
| -1.12% | -0.19% | +36.83% | +136.73% | 8.99B | |
| +1.52% | +3.77% | +49.89% | -4.79% | 6.88B | |
| -0.17% | -2.92% | +13.13% | +30.45% | 6.62B | |
| -0.59% | -4.15% | +2.49% | +191.04% | 6.43B | |
| -7.92% | -22.19% | -35.23% | -0.12% | 5.75B | |
| Average | -0.88% | -2.99% | +9.69% | +63.51% | 14.12B | |
| Weighted average by Cap. | +0.03% | -1.39% | +25.82% | +82.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 795M 8.25M 7.25M 6.74M 6.19M 11.62M 11.8M 80.06M 31.28M 391M 30.99M 30.32M 1.35B | 826M 8.57M 7.53M 7M 6.43M 12.07M 12.26M 83.15M 32.49M 406M 32.18M 31.49M 1.4B |
| Net income | -196M -2.03M -1.79M -1.66M -1.52M -2.87M -2.91M -19.73M -7.71M -96.32M -7.64M -7.47M -333M | -99.67M -1.03M -909K -845K -776K -1.46M -1.48M -10.04M -3.92M -49M -3.89M -3.8M -169M |
| Net Debt | 55.16M 573K 503K 468K 429K 807K 819K 5.56M 2.17M 27.12M 2.15M 2.1M 93.77M | 75.39M 783K 688K 639K 587K 1.1M 1.12M 7.59M 2.97M 37.07M 2.94M 2.88M 128M |
Employees
323
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ₹64.06 | -2.91% | 28,292 |
| 23/07/26 | ₹65.98 | -1.18% | 20,274 |
| 22/07/26 | ₹66.77 | +0.62% | 9,397 |
| 21/07/26 | ₹66.36 | -2.05% | 13,487 |
| 20/07/26 | ₹67.75 | -2.46% | 28,948 |
- Stock Market
- Stocks
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
